United States· US:58468-0210_fafc0928-a014-4dfc-8f46-e0d8aa6690bc
Aubagio
A teriflunomide product containing teriflunomide, registered in United States by Genzyme Corporation. The same ATC class is registered in 14 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Teriflunomide is registered in 14 of 19 countries.
Countries holding a registration under ATC L04AK02 (teriflunomide), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Teriflunomide · ATC L04AK02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of teriflunomide costs, country by country.
Normalised to the WHO defined daily dose (14 mg), the median price runs from $18.33 in Switzerland to $28.01 in Italy — a ×1.5 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Teriflunomide · price per daily dose (14 mg)
USD · FX 28 Sept 2026
- IT Italy$28.01
- CH Switzerland$18.33
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TERIFLUNOMIDE
- Manufacturer
- Genzyme Corporation
- Country
- United States (US)
- ATC code
- L04AK02
- ATC class
- Teriflunomide
- Defined daily dose
- 14 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1158468021011 BLISTER PACK in 1 CARTON (58468-0210-1) / 5 TABLET, FILM COATED in 1 BLISTER PACK
- ndc1158468021031 BLISTER PACK in 1 CARTON (58468-0210-3) / 5 TABLET, FILM COATED in 1 BLISTER PACK
- ndc1158468021041 BOTTLE in 1 CARTON (58468-0210-4) / 30 TABLET, FILM COATED in 1 BOTTLE
- ndc1158468-0210-1
- ndc1158468-0210-3
- ndc1158468-0210-4
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
668 interactions on record for teriflunomide.
Graded by severity as the source publishes them — 542 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Teriflunomide · interactions on record
668 records
- 542 severe
- 116 moderate
- 10 minor
Most severe, free to view
- ClotrimazoleA01AB18severe
- Chenodeoxycholic acidA05AA01severe
- PrednisoloneA07EA01severe
- HydrocortisoneA07EA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Teriflunomide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAREGALUKrka, d.d., Novo mesto, Novo mesto
- PolandAregaluKrka, d.d., Novo mesto
- SpainAUBAGIO 14 MG COMPRIMIDOS RECUBIERTOS CON PELICULASanofi-Aventis Groupe
- SwitzerlandAubagio
- FinlandAubagioAbacus Medicine A/S
- IcelandAUBAGIOSanofi Winthrop Industrie
- SwedenAUBAGIO 14 mg Filmdragerad tablettSanofi Winthrop Industrie
- NetherlandsAUBAGIO 14 mg, filmomhulde tabletSanofi Winthrop Industrie
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Terebyo, Teriflunomid +pharma
- Belgium · Terebyo, Teriflunomide Eg
- Bulgaria · Terebyo, Teriflunomide Msn
- Cyprus · Aregalu, Arogio
- Czechia · Aregalu, Boxarid
- Germany · Terebyo, Teriflago
- Denmark · Clefirem, Teriflunomid Devatis
- Estonia · Aregalu, Boxarid
- Spain · Clefirem, Teriflunomida Aurovitas
- Finland · Clefirem, Teriflunomide Avansor
- France · Terebyo, Teriflunomide Arrow
- United Kingdom (Northern Ireland) · Teriflunomide, Teriflunomide Abdi
- Greece · Aregalu, Arogio
- Croatia · Aregalu, Telirem
- Hungary · Aregalu, Arogio
- Ireland · Teriflunomide Clonmel
- Iceland · Aubagio, Feple
- Italy · Clefirem, Terebyo
- Liechtenstein · Aubagio, Teriflunomide Accord
- Lithuania · Aregalu, Boxarid
- Luxembourg · Teriflunomide Eg, Teriflunomide Eg (Eurogenerics)
- Latvia · Aregalu, Boxarid
- Malta · Telirem, Tergio
- Netherlands · Teriflox, Teriflunomide Abdi
- Norway · Aubagio, Clefirem
- Poland · Aregalu, Boxarid
- Portugal · Teriflunomida Basi, Teriflunomida Bluepharma
- Romania · Aregalu, Boxarid
- Sweden · Clefirem, Teriflunomid Devatis
- Slovenia · Aregalu, Clefirem
- Slovakia · Aregalu, Boxarid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ef6f0c40-0b4c-4ee5-b4c6-da39226dffd2 GET /v1/drugs/ef6f0c40-0b4c-4ee5-b4c6-da39226dffd2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "14",
"substance": "TERIFLUNOMIDE",
"productndc": "58468-0210",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA202992",
"marketing_category": "NDA"
}See everything about teriflunomide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.